Effects of Neuroleptic Treatment on Symptoms of Schizophrenia and Plasma Homovanillic Acid Concentrations

Michael Davidson, Renè S. Kahn, Peter Knott, Ramy Kaminsky, Mark Cooper, Kimberly Dumont, Seth Apter, Kenneth L. Davis

Research output: Contribution to journalArticlepeer-review

Abstract

• Measurement of plasma concentrations of the dopamine metabolite, homovanillic acid, is an indirect tool to assess changes in dopamine turnover in schizophrenic patients. Plasma homovanillic acid concentrations have been reported to decrease during neuroleptic treatment, with the decrement correlating with symptomatic improvement in symptoms of schizophrenia. The present study tested the hypothesis that neuroleptic drugs decrease plasma homovanillic acid concentrations in those schizophrenic patients who improve with administration of neuroleptic drugs but not in patients who fail to display a treatment response. Twenty schizophrenic men who remained drug free for at least 2 weeks were treated with 20 mg/d of haloperidol for 5 weeks. Symptoms and plasma homovanillic acid concentrations were assessed on the last drug-free day and weekly for 5 weeks. Mean plasma homovanillic acid concentrations decreased in the group of patients who responded to neuroleptic treatment and did not change in the group of patients who did not improve. These findings suggest that there may be a qualitative distinction between responders and nonresponders to dopamine antagonists.

Original languageEnglish
Pages (from-to)910-913
Number of pages4
JournalArchives of General Psychiatry
Volume48
Issue number10
DOIs
StatePublished - Oct 1991
Externally publishedYes

Fingerprint

Dive into the research topics of 'Effects of Neuroleptic Treatment on Symptoms of Schizophrenia and Plasma Homovanillic Acid Concentrations'. Together they form a unique fingerprint.

Cite this